Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus

Pranay Wal; Shruti Rathore; Namra Aziz; Yash Kumar Singh; Arpit Gupta

doi:10.1186/s43044-023-00345-6

Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus

Egypt Heart J. 2023 Apr 7;75(1):26. doi: 10.1186/s43044-023-00345-6.

Authors

Pranay Wal¹, Shruti Rathore², Namra Aziz³, Yash Kumar Singh³, Arpit Gupta³

Affiliations

¹ Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, UP, 209305, India. drpranaywal@gmail.com.
² LCIT School of Pharmacy, Bilaspur, Chhattisgarh, 495220, India.
³ Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, UP, 209305, India.

Abstract

Background: Aortic stenosis (AS) is a progressive disease, with no pharmacological treatment. The prevalence of diabetes mellitus (DM) among AS patients is higher than in the general population. DM significantly increases the risk of AS development and progression from mild to severe. The interplay between AS and DM's mechanism is not entirely known yet.

Main body: The increased accumulation of advanced glycation end products (AGEs) was linked to increased valvular oxidative stress, inflammation, expression of coagulation factors, and signs of calcification, according to an analysis of aortic stenotic valves. It is interesting to note that in diabetic AS patients, valvular inflammation did not correlate with serum glucose levels but rather only with long-term glycemic management markers like glycated haemoglobin and fructosamine. Transcatheter aortic valve replacement, which has been shown to be safer than surgical aortic valve replacement, is advantageous for AS patients who also have concurrent diabetes. Additionally, novel anti-diabetic medications have been proposed to lower the risk of AS development in DM patients, including sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonist that target reduction of AGEs-mediated oxidative stress.

Conclusions: There are little data on the effects of hyperglycemia on valvular calcification, but understanding the interactions between them is essential to develop a successful treatment strategy to stop or at least slow the progression of AS in DM patients. There is a link among AS and DM and that DM negatively impacts the quality of life and longevity of AS patients. The sole successful treatment, despite ongoing efforts to find new therapeutic modalities, involves aortic valve replacement. More research is required to find methods that can slow the advancement of these conditions, enhancing the prognosis and course of people with AS and DM.

Keywords: Aortic stenosis; Calcified aortic valve stenosis; Degenerative aortic stenosis; Diabetic mellitus; Valve calcification.

Publication types

Review